Table 1.
Demographic data for study subjects
Variable | Male | Female |
---|---|---|
N | 10 | 10 |
Age (years) | 34.8 ± 7.9 | 38.2 ± 9.3 |
Total body weight (kg) | 76.3 ± 13.3 | 79.5 ± 20.1 |
Ideal body weight (kg) | 74.0 ± 6.8 kg | 58.5 ± 6.3* |
Midazolam dose (mg) | 1.9 ± 0.3 | 2.0 ± 0.5 |
Aspartate aminotransferase (U l−1) | 24.2 ± 4.8 | 24.0 ± 7.4 |
Alanine aminotransferase (U l−1) | 30.1 ± 8.3 | 24.6 ± 9.2 |
Creatinine clearance (ml min−1 1–1.73 m2)† | 99.4 ± 14.7 | 81.3 ± 19.7* |
Length of menstrual cycle (days) | 27.2 ± 2.3 | |
Follicular phase study day | 5.6 ± 1.4 | |
Luteal phase study day | 18.3 ± 3.3 |
Data are given as mean±SD.
P < 0.05 compared with men.
Creatinine clearance was calculated using the Cockcroft and Gault method.